SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001367644-20-000098
Filing Date
2020-06-01
Accepted
2020-06-01 08:45:38
Documents
18
Period of Report
2020-05-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ebs-2020x05x26x02press.htm   iXBRL 8-K 50167
2 EXHIBIT 99 a060120ciadmtorcovid19ca.htm EX-99 11629
8 a060120ciadmtorcovid19ca001.jpg GRAPHIC 280824
9 a060120ciadmtorcovid19ca002.jpg GRAPHIC 275215
10 a060120ciadmtorcovid19ca003.jpg GRAPHIC 215273
  Complete submission text file 0001367644-20-000098.txt   1279802

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ebs-20200601.xsd EX-101.SCH 4492
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ebs-20200601_cal.xml EX-101.CAL 662
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ebs-20200601_def.xml EX-101.DEF 1512
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ebs-20200601_lab.xml EX-101.LAB 27268
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ebs-20200601_pre.xml EX-101.PRE 14152
15 EXTRACTED XBRL INSTANCE DOCUMENT ebs-2020x05x26x02press_htm.xml XML 4372
Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33137 | Film No.: 20931159
SIC: 2834 Pharmaceutical Preparations